ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,145, issued on Oct. 20, was assigned to COREPHARM BIO Co. LTD. (Gyeonggi-do, South Korea).
"Pharmaceutical composition comprising udenafil" was invented by Sang Wook Kim (Gyeonggi-do, South Korea), Hyun Tae Lim (Gyeonggi-do, South Korea), Young Lae Kim (Gyeonggi-do, South Korea) and Jeong Tae Kim (Gyeonggi-do, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition comprising udenafil or a pharmaceutically acceptable salt thereof as an active ingredient, a pH adjusting agent, and cyclodextrin or a derivative thereof."
The patent was filed on July 24, 2020, under Application No. 17/62...